This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Sept. 26, 2011 /PRNewswire-Asia-FirstCall/ China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in
the People's Republic of China, today announced that it will participate in the Jefferies 2011 Global Healthcare Conference on
September 27 and 28, 2011 in
Ming Yin, China Biologic's Vice President of Finance, will present at the conference on
Wednesday, September 28 at
Investors interested in meeting with China Biologic during the conference should please contact their Jefferies representative.
About China Biologic Products, Inc.
China Biologic Products, Inc., through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co., Ltd. and Guizhou Taibang Biological Co., and its equity investment in Xi'an Huitian Blood Products Co., Ltd., is one of the leading plasma-based biopharmaceutical companies in
China. The Company is a fully integrated biologic products company with plasma collection, production and manufacturing, research and development, and commercial operations. The Company's plasma-based biopharmaceutical products are irreplaceable during medical emergencies and are used for the prevention and treatment of various diseases. The Company sells its products to hospitals and other healthcare facilities in
China. Please see the Company's website at
www.chinabiologic.com for additional information.
Y. Tristan KuoChief Financial OfficerChina Biologic Products, Inc.Telephone: +86 53 8620 2206Email:
SOURCE China Biologic Products, Inc.